[1]时佳,叶晨,杨宗国,等.非危重型新型冠状病毒肺炎97例临床观察[J].西部中医药,2022,35(03):5-8.[doi:10.12174/j.issn.2096-9600.2022.03.02]
 SHI Jia,YE Chen,YANG Zongguo,et al.Clinical Observation on 97 Patients with Non-critical Type COVID-19[J].Western Journal of Traditional Chinese Medicine,2022,35(03):5-8.[doi:10.12174/j.issn.2096-9600.2022.03.02]
点击复制

非危重型新型冠状病毒肺炎97例临床观察
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年03期
页码:
5-8
栏目:
新冠肺炎
出版日期:
2022-03-15

文章信息/Info

Title:
Clinical Observation on 97 Patients with Non-critical Type COVID-19
作者:
时佳12 叶晨1 杨宗国1 陆云飞1 吕莹1 徐庆年1 汤伯宗1 殷科珊1 卢洪洲1 陈晓蓉1
1.上海市公共卫生临床中心,上海 201508
2.南京中医药大学
Author(s):
SHI Jia12 YE Chen1 YANG Zongguo1 LU Yunfei1 LYU Ying1 XU Qingnian1 TANG Bozong1 YIN Keshan1 LU Hongzhou1 CHEN Xiaorong1
1.Shanghai Public Health of Clinical Center, Shanghai 201508, China
2.Nanjing University of Chinese Medicine
关键词:
新型冠状病毒肺炎临床特征预后
Keywords:
coronaviruspneumoniaclinical characteristicsprognosis
分类号:
R254
DOI:
10.12174/j.issn.2096-9600.2022.03.02
文献标志码:
A
摘要:
目的观察非危重型新型冠状病毒肺炎患者的临床特征,分析总结其发病规律及演变。 方法收集并分析97例上海市公共卫生临床中心收治住院的非危重型新型冠状病毒肺炎患者临床信息。 结果1)97例患者中男性占多数(54.64%),中位年龄为45岁,96.91%的患者有明确流行病学史。2)常见症状表现为发热(79.38%)、咳嗽/干咳(51.55%)、乏力(40.21%)、纳差(37.11%)、咽痛/痒(36.08%)、腹泻(24.74%)、出汗(22.68%)、鼻塞(17.53%)、头痛/晕(15.46%)、流涕(15.46%)。3)肺部CT以多肺叶病变为主,累及范围广;患者入院时白细胞、血小板、淋巴细胞计数、CD3、CD8、CD4、CD45淋巴细胞计数下降明显,与出院时比较,差异具有统计学意义(P<0.05);C反应蛋白、血沉、乳酸脱氢酶、肌红蛋白、触珠蛋白、酸性糖蛋白、纤维蛋白原、D-D二聚体明显升高,与出院时比较差异具有统计学意义(P<0.05)。4)所有患者均接受抗病毒治疗,94.85%的患者联合使用中药/中成药,35.05%的患者使用抗生素治疗。 结论97例非危重型新型冠状病毒肺炎患者呈病毒感染特征,预后大多良好。
Abstract:
ObjectiveTo analyze and sum up the pathogenesis and evolution of non-crtical type COVID-19 by observing clinical characteritistcs of the patients. MethodsClinical information of 97 cases of non-critical type COVID-19, hospitalized in Shanghai public health of clinical center were collected. Results1)Male are the most among 97 patients (54.64%), median age is 45 years old, 96.91% of the patients have clear epidemiological histories. 2) the common symptoms are fever (79.38%), cough/dry cough (51.55%), weakness (40.21%), poor appetite (37.11%), sore throat/pharyngeal itching(36.08%), diarrhea (24.74%), sweating (22.68%), nasal obstruction (17.53%), headache/vertigo (15.46%), runny nose (15.46%). 3) pulmonary CT manifests multi lobe lesions mainly, involving a wide range. White blood cells (WBC), platelet and lymphocyte count, CD3, CD8, CD4, CD45 decreased notably when the patients were admitted, the difference had statistical meaning when compared with the discharge time (P<0.05); CRP, ESR, LDH, myoglobin, haptoglobin, acid glycoprotein, fibrinogen and D-D dimer increased significantly, and the difference showed statistical meaning (P<0.05). 4)all the patients accepted antiviral therapy, 94.85% of the patients were given with materia medica/Chinese patent medicine, and 35.05% were treated by antibiotics. ConclusionAll 97 patients with non-crtical type COVID-19 present the characteritics of viral infection, and most have a good prognosis.

相似文献/References:

[1]燕忠生,魏千程,李俊,等.三种不同功效中药注射制剂治疗放射性肺炎的实验研究[J].西部中医药,2014,27(03):36.
 YAN Zhongsheng,WEI Qiancheng,LI Jun,et al.Experimental Study on Treating Radiation Pneumonitis by Three Kinds of Different Herbal Injections[J].Western Journal of Traditional Chinese Medicine,2014,27(03):36.
[2]李丹,姚丹△.酚妥拉明联合肺部中频理疗在治疗小儿肺炎中的应用[J].西部中医药,2017,30(12):80.
 LI Dan,YAO Dan.Application of Phentolamine Combined with Pulmonary Intermediate Frequency Physiotherapy to the Treatment for Infantile Pneumonia[J].Western Journal of Traditional Chinese Medicine,2017,30(03):80.
[3]王文学,唐宝莉,李小雪.加味麻杏石甘汤治疗痰热郁肺型小儿肺炎157例[J].西部中医药,2019,32(08):82.
 WANG Wenxue,TANG Baoli,LI Xiaoxue.Treating 157 Cases of Infantile Pneumonia of Phlegm-heat Stagnating Lung Pattern with Modified Maxing Shigan Decoction[J].Western Journal of Traditional Chinese Medicine,2019,32(03):82.
[4]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
 SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(03):18.
[5]杨晓慧,何菊邻.中医药治疗小儿肺炎的知识图谱分析[J].西部中医药,2020,33(03):73.[doi:10.12174/j.issn.1004-6852.2020.03.20]
 YANG Xiaohui,HE Julin.Knowledge Map Analysis of TCM in Treating Infantile Pneumonia[J].Western Journal of Traditional Chinese Medicine,2020,33(03):73.[doi:10.12174/j.issn.1004-6852.2020.03.20]
[6]苏莉,刘永民,刘永红,等.新型冠状病毒肺炎眼传播及其防控探讨[J].西部中医药,2020,33(S1):80.
 SU Li,LIU Yongmin,LIU Yonghong,et al.On Eye Transmission, the Prevention and Control of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(03):80.
[7]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
 ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(03):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[8]胡凤林,赵青威,余国友,等.从德尔塔到奥密克戎——中医药治疗COVID-19的延续与变化[J].西部中医药,2022,35(07):1.[doi:10.12174/j.issn.2096-9600.2022.07.01]
 HU Fenglin,ZHAO Qingwei,YU Guoyou,et al.From Delta to Omicron: the Continuation and Changes of TCM Therapy[J].Western Journal of Traditional Chinese Medicine,2022,35(03):1.[doi:10.12174/j.issn.2096-9600.2022.07.01]
[9]王 雷,李盛华,周明旺.新型冠状病毒肺炎疫情下骨伤科疾病的诊疗思考[J].西部中医药,2020,33(S1):11.
 Under the Impact of COVID-9 Epidemic.Reflection on the Diagnosis and Treatment of Orthopedic Diseases[J].Western Journal of Traditional Chinese Medicine,2020,33(03):11.
[10]王雷,李盛华,周明旺.新型冠状病毒肺炎疫情下骨伤科疾病的诊疗思考[J].西部中医药,2020,33(03):5.[doi:10.12174/j.issn.1004-6852.2020.03.02]
 WANG Lei,LI Shenghua,ZHOU Mingwang.Reflection on the Diagnosis and Treatment of Orthopedic Diseases Under the Impact of COVID-19 Epidemic[J].Western Journal of Traditional Chinese Medicine,2020,33(03):5.[doi:10.12174/j.issn.1004-6852.2020.03.02]

备注/Memo

备注/Memo:
时佳(1988—),女,硕士学位,主治医师。中华中医药学会肝胆病分会青年委员,江苏省中医药学会感染病分会青年委员。研究方向:传染性疾病的中西医结合治疗。国家科技重大专项基金项目(2017ZX10305501);上海市卫计委“病毒性肺炎中医诊疗方案研究”项目(2018LQ014);上海市中医药管理局中医药防治新型冠状病毒肺炎应急专项(2020NCP001);中西医结合课题(ZHYY-ZXYJHZX-1-201703)。
更新日期/Last Update: 2022-06-24